import type { Metadata } from 'next'
import Image from 'next/image'
import Link from 'next/link'
import { buildPageMetadata } from '../../../../src/lib/seo'
import AuthorityJsonLd from '@/components/seo/AuthorityJsonLd'
import AuthorityBreadcrumbs from '@/components/navigation/AuthorityBreadcrumbs'
import LegacyGuideFAQ from '@/components/LegacyGuideFAQ'
import LegacyGuideQuickAnswer from '@/components/LegacyGuideQuickAnswer'
import References from '@/components/References'
import { ArticleLayout, TableOfContents } from '@/components/articles'
import type { Heading } from '@/components/articles'

export const metadata: Metadata = buildPageMetadata({
  title: 'Dipping Tobacco Alternatives: Lower-Risk Options & Quitting Evidence (2026)',
  description:
    'Smokeless-tobacco-specific cessation evidence for counseling, varenicline, nicotine replacement, nicotine pouches, oral substitutes, and cardiovascular/oral-health risk.',
  path: '/guides/other/healthy-dipping-tobacco-alternatives/',
  openGraphType: 'article',
})

const FAQS = [
  {
    question: 'What is the healthiest replacement for dipping tobacco?',
    answer:
      'The strongest health goal is to stop smokeless tobacco and, if possible, end nicotine dependence rather than replace dip indefinitely with another pouch. Smokeless-tobacco-specific evidence supports behavioral counseling and varenicline; nicotine replacement therapy may also help, with lower certainty. Non-nicotine oral substitutes can help replace the mouth habit but do not treat nicotine dependence.',
  },
  {
    question: 'Are nicotine pouches like ZYN healthy?',
    answer:
      'No. Removing tobacco leaf can reduce exposure to some tobacco-specific toxicants, but nicotine pouches still deliver addictive nicotine and are not cardiovascular-health products. Long-term comparative cardiovascular risk is still incompletely defined, and they are not the same as FDA-approved nicotine replacement medicines.',
  },
  {
    question: 'Does bupropion help people quit smokeless tobacco?',
    answer:
      'Current smokeless-tobacco-specific evidence does not show a clear benefit. A 2025 Cochrane review found low-certainty evidence that bupropion did not improve quit rates versus placebo, unlike the more favorable evidence for counseling and varenicline.',
  },
  {
    question: 'Can supplements reverse carotid inflammation or plaque caused by dip?',
    answer:
      'No supplement has been shown to reverse carotid plaque or specifically treat carotid inflammation from smokeless-tobacco exposure. The evidence-based priorities are stopping tobacco exposure, addressing nicotine dependence, and managing established cardiovascular risk factors with appropriate clinical care.',
  },
] as const

const REFS = [
  {
    n: 1,
    text: 'Cochrane Review. Interventions for smokeless tobacco use cessation. 2025. PMID 40232040.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/40232040/',
  },
  {
    n: 2,
    text: 'Moafa I. The effectiveness of nicotine replacement therapy on oral smokeless tobacco cessation and reduction rate: a systematic review. Tob Prev Cessat. 2025. PMID 41112191.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/41112191/',
  },
  {
    n: 3,
    text: 'Fagerstrom K, et al. Stopping smokeless tobacco with varenicline: randomized double-blind placebo-controlled trial. BMJ. 2010. PMID 21134997.',
    url: 'https://pubmed.ncbi.nlm.nih.gov/21134997/',
  },
  {
    n: 4,
    text: 'American Heart Association. Impact of Smokeless Oral Nicotine Products on Cardiovascular Disease: Implications for Policy, Prevention and Treatment. 2024.',
    url: 'https://professional.heart.org/en/science-news/impact-of-smokeless-oral-nicotine-products-on-cardiovascular-disease/top-things-to-know',
  },
  {
    n: 5,
    text: 'CDC. Health Effects of Smokeless Tobacco.',
    url: 'https://www.cdc.gov/tobacco/other-tobacco-products/smokeless-tobacco-health-effects.html',
  },
  {
    n: 6,
    text: 'FDA. FDA-approved and FDA-cleared smoking cessation products can help people quit tobacco.',
    url: 'https://www.fda.gov/consumers/consumer-updates/want-quit-smoking-fda-approved-and-fda-cleared-cessation-products-can-help',
  },
]

const HEADINGS: Heading[] = [
  { id: 'evidence-map', text: 'What Helps People Quit Smokeless Tobacco', level: 2 },
  { id: 'pouches', text: 'Nicotine Pouches: Lower Toxicant Does Not Mean Healthy', level: 2 },
  { id: 'carotid', text: 'Carotid and Cardiovascular Claims', level: 2 },
  { id: 'safety', text: 'When Medical Evaluation Matters', level: 2 },
  { id: 'bottom-line', text: 'Bottom Line', level: 2 },
]

export default function Page() {
  const toc = <TableOfContents headings={HEADINGS} />

  return (
    <ArticleLayout toc={toc} zone="harm-reduction">
      <div className="space-y-10">
        <AuthorityJsonLd
          title="Dipping Tobacco Alternatives: Lower-Risk Options and Quitting Evidence"
          description="Smokeless-tobacco-specific cessation evidence for counseling, varenicline, nicotine replacement, nicotine pouches, and non-nicotine oral substitutes."
          url="https://thehippiescientist.net/guides/other/healthy-dipping-tobacco-alternatives/"
          type="MedicalWebPage"
          citationUrls={REFS.map((ref) => ref.url)}
        />
        <AuthorityBreadcrumbs
          items={[
            { label: 'Home', href: '/' },
            { label: 'Guides', href: '/guides/' },
            { label: 'Dipping Tobacco Alternatives' },
          ]}
        />

        <section className="hero-shell rounded-[2rem] border border-brand-900/10 p-6 shadow-card sm:p-10">
          <p className="eyebrow-label">Harm Reduction Review · Updated August 16, 2026</p>
          <h1 className="mt-3 text-3xl font-semibold tracking-tight text-ink sm:text-4xl">
            Dipping Tobacco Alternatives: Lower-Risk Options Are Not the Same as Healthy Products
          </h1>
          <p className="detail-reading mt-4 text-muted">
            The best evidence for replacing dip is not a supplement stack or a “clean” nicotine pouch. It is a tobacco-cessation plan matched to smokeless-tobacco evidence: behavioral support, varenicline when appropriate, and possibly nicotine replacement therapy. Non-nicotine oral substitutes can help with ritual and habit cues. Nicotine pouches may reduce some tobacco-specific toxicant exposure compared with dip, but they can maintain addiction and are not harmless.
          </p>
          <figure className="mt-6">
            <div className="overflow-hidden rounded-2xl border border-brand-900/10 bg-white shadow-sm">
              <Image src="/images/guides/healthy-dipping-tobacco-alternatives.jpg" alt="Non-tobacco oral substitutes beside a tobacco-cessation evidence review" width={1536} height={1024} priority className="h-auto w-full" />
            </div>
            <figcaption className="mt-3 text-center text-sm text-muted">The goal is less exposure and less dependence—not a healthier-looking nicotine package.</figcaption>
          </figure>
        </section>

        <LegacyGuideQuickAnswer referencesHref="#references">
          <p>
            For smokeless-tobacco cessation, counseling/brief advice and varenicline have the clearest current evidence; nicotine replacement therapy may help, but the certainty is lower [1-3]. The same Cochrane review did not find clear benefit from bupropion for smokeless-tobacco quitting [1]. Nicotine pouches remain addictive and should not be described as healthy or as cardiovascular-protective products [4]. No supplement has established evidence for reversing carotid plaque caused by dip.
          </p>
        </LegacyGuideQuickAnswer>

        <section id="evidence-map" data-answer-engine-table="true" className="max-w-5xl space-y-4 scroll-mt-24">
          <h2 className="text-3xl font-semibold tracking-tight text-ink">What helps people quit smokeless tobacco?</h2>
          <div className="overflow-x-auto rounded-2xl border border-brand-900/10 bg-white/90 dark:border-white/10 dark:bg-white/5">
            <table className="min-w-[860px] w-full text-left text-sm">
              <caption className="sr-only">Smokeless tobacco cessation options and current evidence</caption>
              <thead>
                <tr className="border-b border-brand-900/10 text-ink">
                  <th scope="col" className="p-4">Approach</th>
                  <th scope="col" className="p-4">Current evidence</th>
                  <th scope="col" className="p-4">Practical interpretation</th>
                </tr>
              </thead>
              <tbody className="divide-y divide-brand-900/10 text-muted">
                <tr>
                  <th scope="row" className="p-4 font-semibold text-ink">Counseling / brief advice</th>
                  <td className="p-4">Moderate-certainty evidence of improved quit rates [1]</td>
                  <td className="p-4">Behavioral support is a core treatment, not an optional add-on.</td>
                </tr>
                <tr>
                  <th scope="row" className="p-4 font-semibold text-ink">Varenicline</th>
                  <td className="p-4">Moderate-certainty benefit versus placebo in smokeless-tobacco trials [1,3]</td>
                  <td className="p-4">A clinician-managed prescription option with direct smokeless-tobacco evidence.</td>
                </tr>
                <tr>
                  <th scope="row" className="p-4 font-semibold text-ink">Nicotine replacement therapy</th>
                  <td className="p-4">Possible quit benefit; certainty lower and results heterogeneous [1,2]</td>
                  <td className="p-4">Regulated cessation therapy is different from a consumer nicotine pouch.</td>
                </tr>
                <tr>
                  <th scope="row" className="p-4 font-semibold text-ink">Bupropion</th>
                  <td className="p-4">No clear smokeless-tobacco cessation benefit in current low-certainty evidence [1]</td>
                  <td className="p-4">Do not import cigarette-cessation evidence into dip without qualification.</td>
                </tr>
                <tr>
                  <th scope="row" className="p-4 font-semibold text-ink">Non-nicotine oral substitutes</th>
                  <td className="p-4">Habit/cue replacement rather than pharmacologic dependence treatment</td>
                  <td className="p-4">Useful for the oral ritual; does not treat nicotine withdrawal by itself.</td>
                </tr>
              </tbody>
            </table>
          </div>
        </section>

        <section id="pouches" className="card-premium max-w-4xl space-y-4 p-6 scroll-mt-24">
          <h2 className="text-2xl font-semibold text-ink">Nicotine pouches: lower toxicant does not mean healthy</h2>
          <p className="text-sm leading-7 text-muted">
            A tobacco-free nicotine pouch can remove exposure to cured tobacco leaf and some tobacco-specific toxicants. That is a meaningful harm-reduction distinction, but it does not erase nicotine dependence or prove long-term cardiovascular safety. The American Heart Association notes that oral nicotine products can sustain substantial nicotine exposure and that long-term comparative health effects remain incompletely characterized [4].
          </p>
          <p className="text-sm leading-7 text-muted">
            Consumer nicotine pouches are also not equivalent to FDA-approved nicotine replacement products used as cessation medicines. “Tobacco-free,” “synthetic nicotine,” and “cessation therapy” are not interchangeable labels.
          </p>
        </section>

        <section id="carotid" className="card-premium max-w-4xl space-y-4 p-6 scroll-mt-24">
          <h2 className="text-2xl font-semibold text-ink">Carotid and cardiovascular claims</h2>
          <p className="text-sm leading-7 text-muted">
            Smokeless tobacco is associated with important oral and cardiovascular harms [4,5]. But the right response to concern about carotid disease is not a supplement shopping list. No omega-3, curcumin, garlic, nattokinase, or other supplement has been shown to reverse carotid plaque specifically because someone used dip.
          </p>
          <p className="text-sm leading-7 text-muted">
            If carotid stenosis, plaque, bruit, transient neurologic symptoms, or established cardiovascular disease is present, the evidence-based pathway is clinical risk assessment and treatment of the actual risk factors—not replacing tobacco with an “anti-inflammatory” supplement.
          </p>
        </section>

        <section id="safety" className="rounded-2xl border border-rose-900/15 bg-rose-50/80 p-5 text-sm leading-7 text-rose-950 scroll-mt-24">
          <h2 className="text-xl font-semibold">When medical evaluation matters</h2>
          <p className="mt-2">
            Seek urgent medical care for face drooping, arm weakness, speech difficulty, sudden one-sided numbness, sudden vision loss, chest pain, fainting, or other acute neurologic/cardiovascular symptoms. Oral lesions that persist, bleed, ulcerate, or change should also be evaluated rather than attributed to “irritation from dip.”
          </p>
        </section>

        <section id="bottom-line" className="card-premium max-w-4xl space-y-4 p-6 scroll-mt-24">
          <h2 className="text-2xl font-semibold text-ink">Bottom line</h2>
          <p className="text-sm leading-7 text-muted">
            There is no healthy dipping product. The highest-value move is to stop smokeless tobacco and reduce nicotine dependence using interventions with direct cessation evidence. Counseling and varenicline have the clearest current support; NRT may help; bupropion should not be marketed as a proven smokeless-tobacco cessation aid; and nicotine pouches belong in a harm-reduction discussion, not a health-product ranking [1-4].
          </p>
        </section>

        <LegacyGuideFAQ questions={[...FAQS]} pagePath="/guides/other/healthy-dipping-tobacco-alternatives/" referencesHref="#references" />

        <div className="flex flex-wrap gap-4 border-t border-brand-900/10 pt-4">
          <Link href="/guides/" className="text-sm font-semibold text-brand-800 hover:underline">Back to guides →</Link>
          <Link href="/safety-checker/" className="text-sm font-semibold text-brand-800 hover:underline">Safety checker →</Link>
        </div>
      </div>
      <div id="references" className="scroll-mt-24">
        <References refs={REFS} />
      </div>
    </ArticleLayout>
  )
}
